Pfs Investments »

Halozyme Therapeutics shares owned by Pfs Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Pfs Investments from 13F filings

Historical chart of Pfs Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Pfs Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Pfs Investments

Quarter filed Position value Share count Share price at filing
2023-03-31 $3.7M 97k 38.33
2022-12-31 $3.5M 61k 56.90

More positions owned by Pfs Investments

Ishares Trust Mbs Etf Etf (MBB)
Spdr Index Shares Fun Etf (SPDW)
Spdr Series Trust Prt Etf (SPYG)
Invesco Exch Traded F Etf (QQQM)
Ishares Trust Core S& Etf (IVV)
Spdr Series Trust Prt Etf (SPYV)
Ishares Trust Usa Qua Etf (QUAL)
Spdr Index Shares Fun Etf (SPEM)
Invesco Qqq Trust Uni Etf (QQQ)
Invesco Exch Trd Slf Etf (OMFL)
Invesco Exchange Trad Etf (RSP)
J P Morgan Exchange-t Etf (JEPI)
Ishares Trust Core Ms Etf (IEFA)
Comcast Corp Com Cl A Common (CMCSA)
Cisco Systems Common (CSCO)

View all positions for Pfs Investments

Top funds holding Halozyme Therapeutics

Vanguard Group
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
Jennifer Ranahan
TD Asset Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Arrowpoint Asset Management
Goldman Sachs Group
T. Rowe Price Associates
Norges Bank Investment Management
Bank of New York Mellon
Bank of America Corporation
New York State Common Retirement Fund

View all funds holding Halozyme Therapeutics